@FierceBiotech: Lilly takes the lead on AstraZeneca's Alzheimer's drug in $500M deal. News | Follow @FierceBiotech
@JohnCFierce: Biotech R&D is changing. Don't get left behind. (A shameless plug for upcoming executive breakfast panel in Boston). More | Follow @JohnCFierce
@DamianFierce: Oxygen Bio will soon be Tenax Therapeutics. Release | Follow @DamianFierce
@EmilyMFierce: Great piece on the trials and tribulations of stem cell research. Report from the NYT | Follow @EmilyMFierce
> GlaxoSmithKline ($GSK) has taken an option on the muscle disease drugs developed at South San Francisco-based Five Prime. The deal dates back 4 years. Five Prime gets a payment of $1.5 million in connection with the option exercise and up to $122.5 million in preclinical, development and commercial-related milestone payments and royalties in the low- to mid-single-digit range on net sales of products related to the target. Release
> Cambridge, MA-based Dimension Therapeutics, a gene therapy upstart, named Annalisa Jenkins as its new CEO. Jenkins recently wrapped a stint as head of R&D at Merck KGaA and earlier worked for Bristol-Myers Squibb ($BMY). Release
> AstraZeneca ($AZN) has opened up a new Global Technology Centre to build up its IT infrastructure. The center plans to have a staff of 300 by the end of this year. Story
Medical Device News
@FierceMedDev: ICYMI yesterday: Danaher cements commitment to dental with $2.2B Nobel acquisition. Article | Follow @FierceMedDev
@MichaelGFierce: Liposome research adds up to better #cancer treatment options. More | Follow @MichaelGFierce
> WSJ: What are the costs and benefits of early cancer screening? Item
> Harvard researchers develop dialysis device to fight Ebola. Story
> Former Alere execs assemble $3.8B take-private offer. Report
Pharma News
@FiercePharma: Top-read in FierceAnimalHealth Mon: FDA seeks input on conditional approvals for new animal health products. Story | Follow @FiercePharma
@EricPFierce: Merck KGaA turns to India's Lupin to manufacture $2B worth of drugs in emerging markets. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: Would Ian Read keep his AZ deal promises? U.K. panel eyes new rules to enforce them. ICYMI yesterday | Follow @CarlyHFierce
> Switzerland wants to slash drug prices? Not so fast, say Novartis and Roche. More
> Allergan, Valeant agree on meeting date. Now, the fight for shareholder votes. Story
> NY sues Actavis and Forest for 'monopoly' on Alzheimer's drug. Report
Biotech Research News
> Notable academic-pharma alliances of 2014. Feature
> Geneva Foundation gets $3M NIH grant for Ebola drug work. News
> Protein stops bone loss in arthritic mice. More
> Google's Calico acquires UT Southwestern compounds for neurodegenerative disorders. Story
> $64M NIH initiative will catalog cell responses to drugs. Article
Pharma Manufacturing News
> Gilead hands Sovaldi manufacturing tech to 7 generics makers. Report
> Merck negotiates huge production deal with Lupin. More
> Hikma opens oncology API plant in Jordan. Article
> India's top drugmakers forecast to invest $8B in production upgrades. Item
> Hospira again reports a human hair discovered in a product. Story